Research Portfolio
We invite you to learn about the Foundation's research grants. The search feature and the table below represent the Foundation's complete research portfolio. You may search the complete list of grants by status (open/active or closed/inactive), research program area, and disease.
If you are interested in a specific research program area, browse the recently funded research by program area.
Filter for Grant pages
Keyword Search for Grant pages
Search Results
|
Title |
Institution |
Investigator |
Status |
Research Program Area |
| 02315-A: Discovering Peptide Targets for Development of Adoptive Cell Therapy for Peripheral T-Cell Lymphoma | North Carolina State University | Paul R. Hess, DVM, PhD | Closed | Oncology - Lymphoma |
| 02304-A: Investigating a Biomarker and Novel Therapeutic Target for Canine Diffuse Large B Cell Lymphoma | North Carolina State University | Jennifer A. Luff, VMD, PhD | Closed | Oncology - Lymphoma |
| 02234-MOU: A Novel Approach for Prevention of Canine Hemangiosarcoma | University of Minnesota | Jaime F Modiano, VMD, PhD | Closed | Oncology - Hemangiosarcoma |
| 02237-A: Capturing Tumor Cells in Canine Blood | Cornell University | Tracy Stokol, PhD | Closed | Oncology |
| 02215: A Cancer Vaccine for Canine Osteosarcoma | University of Florida | Rowan J Milner, BVSc | Closed | Oncology, Oncology - Osteosarcoma |
| 2217: A Novel Mechanism to Regulate the Growth of Canine Hemangiosarcoma | University of Minnesota | Erin B. Dickerson, PhD | Closed | Oncology, Oncology - Hemangiosarcoma |
| 02204-T: Using Enhanced Imaging to Evaluate Tumor Margins for Canine Mammary Cancer and Soft Tissue Sarcoma | Ohio State University | Laura E. Selmic, BVetMed, MPH | Closed | Oncology |
| 02171-MOU: Histiocytic Sarcoma in Bernese Mountain Dogs: Novel Approaches To Treatment | Michigan State University | Vilma Yuzbasiyan-Gurkan, PhD | Closed | Oncology |
| 02091-A: Differentiating between Localized and Disseminated Histiocytic Sarcoma in Bernese Mountain Dogs | National Human Genome Research Institute | Elaine A Ostrander, PhD | Closed | Oncology |
| 02093-A: Sequencing Histiocytic Sarcoma (HS) loci identified by Genetic Association studies in the Bernese Mountain Dog (BMD) | CNRS - University of Rennes | Catherine Andre, PhD | Closed | Oncology |
| 01949-A: Targeting the Cell's Activation Machinery to Halt Tumor Metastasis in Canine Osteosarcoma | Oregon State University | Shay Bracha, DVM, MS | Closed | Oncology - Osteosarcoma |
| 02071: Development of a Therapeutic Brain Tumor Vaccine | University of Minnesota | Grace Elizabeth Pluhar, DVM, PhD | Closed | Oncology |
| 01889-G: Innovations in Prevention, Diagnosis, and Treatment of Cancer - Goldens Lead the Way | University of Minnesota | Jaime F Modiano, VMD, PhD | Closed | Oncology |
| 02092-A: Developing the Use of a Novel Imaging Technique to Define a Dog's Potential Responsiveness to Chemotherapy | Purdue University | Michael O. Childress, DVM, MS | Closed | Oncology - Lymphoma |
| 02081-A: Integrating Cutting Edge Science with Scientific Training to Defeat Hemangiosarcoma | University of Minnesota | Jaime F Modiano, VMD, PhD | Closed | Oncology - Hemangiosarcoma |
| 01918-G: Discovery of Biomarkers to Detect Lymphoma Risk, Classify For Treatment, and Predict Outcome in Golden Retrievers | University of Missouri, Columbia | Jeffrey N. Bryan, DVM | Closed | Oncology - Lymphoma |
| 01929-A: Arginine Dependence: Identification of Cancer's Achilles Heel | University of California, Davis | Carlos O. Rodriguez Jr, DVM, PhD | Closed | Oncology |
| 01925-A: Discovery of Novel Micro-Ribonucleic Acids for Diagnosis and Prognosis of Canine Hemangiosarcoma | Auburn University | Bruce F Smith, VMD, PhD | Closed | Oncology - Hemangiosarcoma |
| 01914-A: Defining the Genes That Contribute to the Development of Soft Tissue Sarcomas | University of Utrecht | Kim Miranda Boerkamp, DVM | Closed | Oncology |
| 1806: A Novel Virus-Based Anti-Tumor Treatment for Canine Osteosarcoma | Auburn University | Bruce F Smith, VMD, PhD | Closed | Oncology - Osteosarcoma |
| 01911-A: Enhanced Hemangiosarcoma Therapy Using a Novel Combination of Drugs That Target Tumor Proliferation | Van Andel Research Institute | Nicholas S. Duesbery, PhD | Closed | Oncology - Hemangiosarcoma |
| 01912-A: Enhancing the Safety and Efficacy of Anti-Cancer Drugs in Dogs | Research Foundation of State University of New York | Javier G. Blanco, PhD | Closed | Oncology |
| 01903-A: Defining the Anti-Tumor Activity of Monocytes in Osteosarcoma | North Carolina State University | Duncan Lascelles, PhD | Closed | Oncology - Osteosarcoma |
| 01759: Disrupting the Differentiation of Cancer Stem Cells to Prevent the Spread of Hemangiosarcoma | University of Minnesota | Jaime F Modiano, VMD, PhD | Closed | Oncology - Hemangiosarcoma |
| 01822: Beyond the Genome: The Intersection of Genes and the Environment in Canine Cancer | University of California, Los Angeles | Robert K Wayne, PhD | Closed | Oncology |
| 1787: Clinical Advancement of a Cancer Vaccine in Dogs | University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Closed | Oncology - Lymphoma |
| 01843: Further Investigation of the Genes Controlling Canine Leukemia to Properly Diagnose and Control the Disease | North Carolina State University | Matthew Breen, PhD | Closed | Oncology |
| 01826: A Novel Treatment for Brain Tumors Using a One Medicine Approach | University of Georgia | Simon R. Platt, BVMS | Closed | Oncology |
| 01876-A: Ensuring That Emerging Stem Cell Treatments Do Not Activate or Exacerbate Cancer in Dogs | Colorado State University | Douglas H Thamm, VMD | Closed | Oncology |
| 01872-A: Using Ultrasound as a Cost Effective and Non-Invasive Technique for Early Diagnosis of Solid Tumors | Louisiana State University | Nathalie Rademacher, Med.Vet. | Closed | Oncology |
| 01557: Narrowing the Search for the Genetic Basis of Histiocytic Malignancies | North Carolina State University | Matthew Breen, PhD | Closed | Oncology |
| 01726-A: Identifying Growth Factors That Promote the Spread of Osteosarcoma | Oregon State University | Stuart Helfand, DVM | Closed | Oncology - Osteosarcoma |
| 01689-A: Increasing the Effectiveness of Radiation Therapy in Treatment of Mast Cell Tumors | Louisiana State University | Keijiro Shiomitsu, DVM | Closed | Oncology |
| 01569: Evaluation of a Novel Drug to Treat Canine Cutaneous Lymphoma | Colorado State University | Douglas H Thamm, VMD | Closed | Oncology - Lymphoma |
| 01703-A: Enhancing Natural Anti-Tumor Immune Responses during Chemotherapy | Auburn University | Annette N. Smith, DVM | Closed | Oncology |
| 01686-A: Identifying Drugs That Will Kill Cancer Stem Cells | Tufts University | Kristine Elaine Burgess, DVM, MS | Closed | Oncology |
| 01692-A: Accurate Diagnosis of Mast Cell Tumor Metastasis | Tufts University | Arthur Donohue-Rolfe, PhD | Closed | Oncology |
| 01704-A: Expression and distribution of Receptor Activator of Nuclear factor kB Ligand (RANK-L) and its receptor RANK in canine osteosarcoma | Oregon State University | Bernard S�guin, DVM, MS | Closed | Oncology - Osteosarcoma |
| 01708-A: Validation of a general method for enrichment of canine cancer stem cells | University of Minnesota | Timothy D. O'Brien, DVM PhD | Closed | Oncology |
| 01577: Identifying the Genes Conferring Risk for Transitional Cell Carcinoma | National Human Genome Research Institute | Elaine A Ostrander, PhD | Closed | Oncology |
| 1585: Evaluating a Safer, Less Toxic Radiation Therapy in the Treatment of Lymphoma | Texas A&M Research Foundation | Michael A. Deveau, DVM, MS | Closed | Oncology - Lymphoma |
| 1093B-T: Positional Cloning of the Gene(s) for Gastric Cancer in the Chow Chow | Tufts Medical Center | Elizabeth McNiel, DVM, PhD | Closed | Oncology |
| 01660: Identifying the Genes That Confer Risk for Osteosarcoma | The Ohio State University | Carlos E. Alvarez, PhD | Open | Oncology - Osteosarcoma |
| 01651: Serum Antibody Reactivity Profiling for Canine Lymphoma Detection and Monitoring | Arizona State University | Stephen A Johnston, PhD | Closed | Oncology - Lymphoma |
| 01698-A: Immunohistochemical quantification of the transcobalamin II protein and receptor in naturally occurring canine tumors. | Bauer Research Foundation | Annette M Sysel, DVM | Closed | Oncology |
| 1633: Novel Therapy for Melanoma, Lymphoma, Meningioma and Nephroblastoma | Texas A&M AgriLife Research | Heather M. Wilson, DVM | Closed | Oncology |
| 01683-A: Improving Resection of Tumors through Enhanced Imaging | University of Pennsylvania | David E Holt, BVSc | Closed | Oncology |
| 01672-A: Isolation and Characterization of Tumor Initiating Cells in Canine Osteosarcoma Cell Lines | Texas A&M Research Foundation | Heather M. Wilson, DVM | Closed | Oncology - Osteosarcoma |
| 01669-A: Determining the Role of Bacterial Infection in Complications after Chemotherapy | University of Wisconsin, Madison | Jonathan F Bach, DVM | Closed | Oncology |
| 01545-A: Pilot Study to Assess Folate Receptor Expression in Canine High-Grade Multicentric Lymphoma | Purdue University | Michael O. Childress, DVM, MS | Closed | Oncology - Lymphoma |
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
